B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma - sprookjes - yvandenbroek - TriplyDB

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

http://www.wikidata.org/entity/Q58701502

about

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

http://www.wikidata.org/entity/Q58701502

description

article publié dans la revue scientifique Scientific Reports

@fr

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

@en

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

@nl

type

label

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

@en

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

@nl

prefLabel

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

@en

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

@nl

P1433

Q58701502-CEC5084E-A07F-4BDD-AB34-975344DB43E0

P1476

Q58701502-7450728D-B388-4F73-9D24-374D693365B7

P2093

Q58701502-5FD869A4-D57D-48BE-AB43-35498AD43F74

Q58701502-8CD18D5A-16BC-4F8E-902C-1937A9A8D698

Q58701502-ABF37143-E368-40A9-BF68-C293048DB821

Q58701502-BFAF8281-61BE-4AFB-B8C0-469DC0DF59C2

Q58701502-D63E4565-5755-4408-A815-5D51DE08F50A

P2860

Q58701502-0507F726-8DEB-4770-A772-16C8E8A9984E

Q58701502-069ADA24-1769-43DF-97A5-3C1191700674

Q58701502-155EC07C-FC8D-4BAB-8488-8414B69C3C39

Q58701502-1AA3E97E-0313-4212-B58E-A0EFFE7CA97D

Q58701502-1CFE89F1-1BE0-446A-BD6B-4379FC901723

Q58701502-1D30051B-7333-417D-A2AC-386ED345A333

Q58701502-233A7C72-437F-4E60-89E6-DC008D677F81

Q58701502-296D1D0B-02FE-4FD0-A208-AE0EFACF2F4A

Q58701502-2ED14459-71F8-494B-B59B-883A5F407554

Q58701502-3AEAA5BB-A97F-402A-B2C1-62651395B9EB

P2888

Q58701502-B0663C4B-1C71-4053-995D-8931A804B37E

P304

Q58701502-F07CF56E-AC87-4F31-A077-8B6299454C82

P31

Q58701502-C4065E7D-A088-4B0C-ACBE-8B006B99A6B6

P356

Q58701502-71E29768-EE5C-4900-B65A-8DA1EEE97BED

P407

Q58701502-DB618AC7-6AE9-4869-95B3-CA6739D4AC52

P433

Q58701502-3B04E907-AB4A-4161-AB41-94469A8D8DF6

P478

Q58701502-FFC02237-2083-4FA1-A41A-12D5EF61009A

P577

Q58701502-86C017D0-C25C-4DFB-B5CC-2495C59E8F33

P6179

Q58701502-BA74ADC9-E323-4311-9E34-6FCA44E5EAB5

P698

Q58701502-F5BE260F-DD63-4FD7-A83F-7CF5775DA958

P932

Q58701502-EBAFFCC7-BB0B-40BD-A6A0-C527CFC5B54A

P356

S41598-018-31212-Z

P1433

Scientific Reports

P1476

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma

@en

P2093

Mingzhi Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaorui Fu

http://www.w3.org/2001/XMLSchema#string

Yanan Li

http://www.w3.org/2001/XMLSchema#string

Yu Chang

http://www.w3.org/2001/XMLSchema#string

Yufeng Shang

http://www.w3.org/2001/XMLSchema#string

P2860

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy

P2888

s41598-018-31212-z

P304

12907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-31212-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106295135

http://www.w3.org/2001/XMLSchema#string

P698

30150635

http://www.w3.org/2001/XMLSchema#string

P932

6110724

http://www.w3.org/2001/XMLSchema#string